UCBJY
UCB SA UNSP/ADR by UCB S.A. (UCBJY)
$29
About UCB SA UNSP/ADR by UCB S.A. (UCBJY)
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$151.76
52 Week Low
$71.16
Market cap
54.1B
Dividend yield
0.56%
Volume
--
Avg. volume
21,289
P/E ratio
37.38
UCB SA UNSP/ADR by UCB S.A. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$151.76
52 Week Low
$71.16
Market cap
54.1B
Dividend yield
0.56%
Volume
--
Avg. volume
21,289
P/E ratio
37.38